2022
Zelceski, Francica et al. MND1 and PSMC3IP control PARP inhibitor sensitivity in mitotic cells. bioRxiv 2022.08.24.505108; doi: https://doi.org/10.1101/2022.08.24.505108.
Liptay et al. MDC1 counteracts restrained replication fork restart and its loss causes chemoresistance in BRCA1/2-deficient mammary tumors. bioRxiv 2022.08.18.504391; doi: https://doi.org/10.1101/2022.08.18.504391.
Bhin et al. Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors. bioRxiv 2022.09.07.506927; doi: https://doi.org/10.1101/2022.09.07.506927.
Gradauskaite V, Inglebert M, Doench J, Scherer M, Dettwiler M, Wyss M, Shrestha N, Rottenberg S, Plattet P. LRP6 Is a Functional Receptor for Attenuated Canine Distemper Virus. mBio. 2023 Feb 28;14(1):e0311422. Epub 2023 Jan 16. PMID: 36645301.
Widmer CA, Klebic I, Domanitskaya N, Decollogny M, Howald D, Siffert M, Essers P, Nowicka Z, Stokar-Regenscheit N, van de Ven M, de Korte-Grimmerink R, Galván JA, Pritchard CEJ, Huijbers IJ, Fendler W, Vens C, Rottenberg S. Loss of the volume-regulated anion channel components LRRC8A and LRRC8D limits platinum drug efficacy. Cancer Res Commun. 2022 Oct 26;2(10):1266-1281. PMID: 36467895.
Inglebert M, Dettwiler M, Hahn K, Letko A, Drogemuller C, Doench J, Brown A, Memari Y, Davies HR, Degasperi A, Nik-Zainal S, Rottenberg S. A living biobank of canine mammary tumor organoids as a comparative model for human breast cancer. Sci Rep. 2022 Oct 27;12(1):18051.. PMID: 36302863.
Dibitetto D, Marshall S, Sanchi A, Liptay M, Badar J, Lopes M, Rottenberg S, Smolka MB. DNA-PKcs promotes fork reversal and chemoresistance. Mol Cell. 2022 Oct 20;82(20):3932-3942.e6. Epub 2022 Sep 20. PMID: 36130596.
Zingg D, Bhin J, Yemelyanenko J, Kas SM, Rolfs F, Lutz C, Lee JK, Klarenbeek S, Silverman IM, Annunziato S, Chan CS, Piersma SR, Eijkman T, Badoux M, Gogola E, Siteur B, Sprengers J, de Klein B, de Goeij-de Haas RR, Riedlinger GM, Ke H, Madison R, Drenth AP, van der Burg E, Schut E, Henneman L, van Miltenburg MH, Proost N, Zhen H, Wientjens E, de Bruijn R, de Ruiter JR, Boon U, de Korte-Grimmerink R, van Gerwen B, Féliz L, Abou-Alfa GK, Ross JS, van de Ven M, Rottenberg S, Cuppen E, Chessex AV, Ali SM, Burn TC, Jimenez CR, Ganesan S, Wessels LFA, Jonkers J. Truncated FGFR2 is a clinically actionable oncogene in multiple cancers. Nature. 2022 Aug;608(7923):609-617. Epub 2022 Aug 10. Erratum in: Nature. 2022 Sep;609(7929):E13. PMID:35948633.
Janowczyk A, Baumhoer D, Dirnhofer S, Grobholz R, Kipar A, de Leval L, Merkler D, Michielin O, Moch H, Perren A, Rottenberg S, Rubbia-Brandt L, Rubin MA, Sempoux C, Tolnay M, Zlobec I, Koelzer VH; Swiss Digital Pathology Consortium (SDiPath). Towards a national strategy for digital pathology in Switzerland. Virchows Arch. 2022 Oct;481(4):647-652. Epub 2022 May 27. PMID: 35622144.
Lingg L, Rottenberg S, Francica P. Meiotic Genes and DNA Double Strand Break Repair in Cancer. Front Genet. 2022 Feb 18;13:831620. PMID: 35251135.
